Target intelligence / Profile preview

Phospholipase C delta-4 (PLCD4)

Target
PLCD4
Molecular classification
Enzyme, Phosphoinositide-specific phospholipase (subclass: Phospholipase C delta family)
01

Overview

Phospholipase C delta-4 (PLCD4) is an enzyme in the delta subclass of phosphoinositide-specific phospholipase C family. It plays an essential role in hydrolyzing phosphatidylinositol 4,5-bisphosphate (PIP2) to generate second messengers, diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3)[1][4]. These messengers activate protein kinase C and release calcium from intracellular stores, respectively, making PLCD4 a key regulator of intracellular signaling, especially calcium-mediated events. PLCD4 is especially important for the acrosome reaction in sperm during fertilization and plays significant roles in cell proliferation, the cell cycle (notably G1/S transition), and may contribute to tumorigenesis when dysregulated. Predominant expression is noted in brain, testes, and regenerating liver, with functional evidence for contributions to both cytoplasmic and nuclear calcium signaling, and possible roles in cellular senescence and oncogenesis[2][5][7].

Other names
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4hPLCD4PLC-delta-4Phosphoinositide phospholipase C-delta-4Phospholipase C-delta-4PLC delta4
02

Mechanism of action

Hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to produce diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3), mediating calcium release and downstream signaling cascades[1][4][5].

03

Biological functions

Signal transductionCalcium ion signaling/mobilizationCell cycle regulationCell proliferationAcrosome reaction in sperm (fertility function)Possible role in cell senescence
04

Disease associations

Cancer (Breast cancer, Testicular cancer)Lynch syndrome 4Hemophagocytic lymphohistiocytosis, familial, 3
05

Safety considerations

Potential oncogenic role when overexpressed; involvement in cell proliferation may contribute to tumorigenesis[5].No drug-related or therapeutic-specific safety concerns described in current literature.
06

Biomarkers

Overexpression may serve as a marker for certain cancers, e.g., breast and testicular cancer[1][5].

Beyond the preview

Go deeper on Phospholipase C delta-4 (PLCD4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipase C delta-4 (PLCD4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call